Potassium supplementation for the management of primary hypertension in adults
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Epidemiological evidence on the effects of potassium on blood pressure is inconsistent.To evaluate the effects of potassium supplementation on health outcomes and blood pressure in people with elevated blood pressure.We searched the Cochrane Library, MEDLINE, EMBASE, Science Citation Index, ISI Proceedings, ClinicalTrials.gov, Current Controlled Trials, CAB abstracts, and reference lists of systematic reviews, meta-analyses and randomised controlled trials (RCTs) included in the review.Inclusion criteria were: 1) RCTs of a parallel or crossover design comparing oral potassium supplements with placebo, no treatment, or usual care; 2) treatment and follow-up >=8 weeks; 3) participants over 18 years, with raised systolic blood pressure (SBP) >=140 mmHg or diastolic blood pressure (DBP) >=85 mmHg); 4) SBP and DBP reported at end of follow-up. We excluded trials where: participants were pregnant; received antihypertensive medication which changed during the study; or potassium supplementation was combined with other interventions.Two reviewers independently extracted data and assessed trial quality. Disagreements were resolved by discussion or a third reviewer. Random effects meta-analyses and sensitivity analyses were conducted.Six RCT's (n=483), with eight to 16 weeks follow-up, met our inclusion criteria. Meta-analysis of five trials (n=425) with adequate data indicated that potassium supplementation compared to control resulted in a large but statistically non-significant reductions in SBP (mean difference: -11.2, 95% CI: -25.2 to 2.7) and DBP (mean difference: -5.0, 95% CI: -12.5 to 2.4). The substantial heterogeneity between trials was not explained by potassium dose, quality of trials or baseline blood pressure. Excluding one trial in an African population with very high baseline blood pressure resulted in smaller overall reductions in blood pressure (SBP mean difference: -3.9, 95% CI: -8.6 to 0.8; DBP mean difference: -1.5, 95% CI: -6.2 to 3.1). Further sensitivity analysis restricted to two high quality trials (n=138) also found non-significant reductions in blood pressure (SBP mean difference: -7.1, 95% CI: -19.9 to 5.7; DBP mean difference: -5.5, 95% CI: -14.5 to 3.5).This systematic review found no statistically significant effect of potassium supplementation on blood pressure. Because of the small number of participants in the two high quality trials, the short duration of follow-up, and the unexplained heterogeneity between trials, the evidence about the effect of potassium supplementation on blood pressure is not conclusive. Further high quality RCTs of longer duration are required to clarify whether potassium supplementation can reduce blood pressure and improve health outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Egger, M., Jüni, P., Bartlett, C., Holenstein, F., & Sterne, J. (2003) · Health Technology Assessment · doi:10.3310/hta7010 · Cited by 1,181
Cited by
Aburto, N. J., Hanson, S., Gutierrez, H., Hooper, L., Elliott, P., & Cappuccio, F. P. (2013) · BMJ · doi:10.1136/bmj.f1378 · Cited by 938
Weaver, C. M. (2013) · Advances in Nutrition · doi:10.3945/an.112.003533 · Cited by 374
Potassium Intake, Stroke, and Cardiovascular Disease
D'Elia, L., Barba, G., Cappuccio, F. P., & Strazzullo, P. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.070 · Cited by 313
“In a more recent meta-analysis (6), hich included only 5 studies featuring a prolonged ollow-up (at least 8 weeks), a favorable impact was also etected; however, the difference was not statistically sigificant after the exclusion of a single outlier study reporting n exceptionally large favorable effect (7).”
BackgroundPotassium Intake, Bioavailability, Hypertension, and Glucose Control
Stone, M., Martyn, L., & Weaver, C. (2016) · Nutrients · doi:10.3390/nu8070444 · Cited by 287
Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension
Rust, P., & Ekmekcioglu, C. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2016_147 · Cited by 286
Potassium, Magnesium, and Calcium: Their Role in Both the Cause and Treatment of Hypertension
Houston, M. C., & Harper, K. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.08575.x · Cited by 282
Du, S., Neiman, A., Batis, C., Wang, H., Zhang, B., Zhang, J., & Popkin, B. M. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.059121 · Cited by 279
The Role of Magnesium in Hypertension and Cardiovascular Disease
Houston, M. (2011) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00538.x · Cited by 276
Ashworth, A., Mitchell, K., Blackwell, J. R., Vanhatalo, A., & Jones, A. M. (2015) · Public Health Nutrition · doi:10.1017/s1368980015000038 · Cited by 109
“However, Cochrane reviews of the effectiveness of K, Mg and Ca supplements concluded that there was insuf fi cient evidence to support their use as hypotensive agents (37 – 39) .”
Peña-Jorquera, H., Cid-Jofré, V., Landaeta-Díaz, L., Petermann-Rocha, F., Martorell, M., Zbinden-Foncea, H., Ferrari, G., Jorquera-Aguilera, C., & Cristi-Montero, C. (2023) · Nutrients · doi:10.3390/nu15143244 · Cited by 103
“However, not all evidence supports this association [225].”
BackgroundBerry, S. E., Mulla, U. Z., Chowienczyk, P. J., & Sanders, T. A. B. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510002904 · Cited by 102
Gee, L. C., & Ahluwalia, A. (2016) · Current Hypertension Reports · doi:10.1007/s11906-015-0623-4 · Cited by 80
A “green” diet-based approach to cardiovascular health? Is inorganic nitrate the answer?
Rathod, K. S., Velmurugan, S., & Ahluwalia, A. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500313 · Cited by 42
Metadata
- Authors
- Dickinson, H. O., Nicolson, D., Campbell, F., Beyer, F. R., & Mason, J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2006-07-19
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4246073291
- Cited by
- 95
- References
- 5
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.